AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.44%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.79M | -3.02M | -4.18M | -3.28M | -2.79M |
| Total Depreciation and Amortization | 528.00K | 43.00K | 43.00K | 54.00K | 319.00K |
| Total Amortization of Deferred Charges | -183.00K | 183.00K | 300.00K | 69.00K | -64.00K |
| Total Other Non-Cash Items | -45.00K | 569.00K | 1.97M | 408.00K | 225.00K |
| Change in Net Operating Assets | -1.10M | -491.00K | -125.00K | -2.33M | 783.00K |
| Cash from Operations | -4.59M | -2.72M | -1.99M | -5.08M | -1.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.00K | -37.00K | -95.00K | 296.00K | 754.00K |
| Cash from Investing | -112.00K | -37.00K | -95.00K | 296.00K | 754.00K |
| Total Debt Issued | -- | -- | 2.50M | 0.00 | 250.00K |
| Total Debt Repaid | -621.00K | -200.00K | 0.00 | -660.00K | -- |
| Issuance of Common Stock | 11.04M | 4.16M | -- | 6.92M | 105.00K |
| Repurchase of Common Stock | -- | -- | -6.70M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.63M | 1.63M | 6.92M | 398.00K | -- |
| Cash from Financing | 8.79M | 5.59M | 2.72M | 6.65M | 355.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.08M | 2.83M | 638.00K | 1.87M | -422.00K |